2011
DOI: 10.1038/onc.2011.535
|View full text |Cite
|
Sign up to set email alerts
|

The immediate early gene Ier2 promotes tumor cell motility and metastasis, and predicts poor survival of colorectal cancer patients

Abstract: Here, we report unbiased screens for genes expressed in metastatic tumor cells that are associated with cell motility. These screens identified Ier2, an immediate early gene of unknown function, as potentially having a role in tumor cell motility and metastasis. Knockdown of Ier2 in 3T3 fibroblasts inhibited their motility upon relief of contact inhibition in monolayer wounding assays. Furthermore, ectopic Ier2 expression promoted the motility and invasiveness of poorly metastatic 1AS pancreatic tumor cells in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
29
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 50 publications
(33 citation statements)
references
References 32 publications
3
29
1
Order By: Relevance
“…Knockdown of the endogenous IER2 by LV-shR infection significantly decreased the HUVECs migration and invasion. This result was in accordance with another study showing that IER2 promoted cell motility and tumor metastasis (13). These findings suggested that knockdown and overexpression of IER2 modulated the general capacity of endothelial cell motility, and the endogenous IER2 expression may be required for endothelial cell migration and invasion.…”
Section: Discussionsupporting
confidence: 82%
See 1 more Smart Citation
“…Knockdown of the endogenous IER2 by LV-shR infection significantly decreased the HUVECs migration and invasion. This result was in accordance with another study showing that IER2 promoted cell motility and tumor metastasis (13). These findings suggested that knockdown and overexpression of IER2 modulated the general capacity of endothelial cell motility, and the endogenous IER2 expression may be required for endothelial cell migration and invasion.…”
Section: Discussionsupporting
confidence: 82%
“…Currently, IER2 has been characterized as a putative nuclear protein that served function as a fibroblast growth factor intracellular binding protein 1-interacting partner (12), and as a transcription factor or transcriptional co-activator for the human myo-inositol 1-phosphate synthase gene involved in the regulation of cellular responses (9,12). Furthermore, data from a previous study indicated that IER2 is involved in the regulation of tumor progression and metastasis (13), although the precise role and signaling mechanism involved remain elusive. In our previous study, microarray was performed to analyze the gene expression profile in response to basic fibroblast growth factor (bFGF), which is a proangiogenic factor (14), at selective time points during different phases of human dermal microvascular endothelial cells morphogenesis (15) in fibrin matrices by bFGF led to a significant upregulation of IER2 within 24 h and a subsequently significant downregulation between 24 and 72 h (data not shown), which prompted the evaluation of whether IER2 participates in the regulation of the endothelial cell morphogenesis and angiogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…4C). IER2 is a DNA-binding protein expressed in activated tumor cells and metastatic tumor cells that can promote cell motility and been reported to correlate with poor metastasis-free and overall survival [52]. Its post-translational modification has not previously been reported.…”
Section: Resultsmentioning
confidence: 99%
“…It is well established that tumors are known as wounds that do not heal, in other words, chronic wounds predispose to tumor formation. Mechanistically, many genes that are involved in response to wounding, such as RHBDF2 and Ier2, have been shown to be prominent factors in the progression and metastasis of cancer (Blaydon et al, 2012;Neeb et al, 2012). Interestingly, product of PLAU gene (uPA) and its receptor have been proved to be key regulators in cancer adhesion, migration and invasion (Han, Nakamura, Mori, Nakamura, & Kakudo, 2005;Laufs, Schumacher, & Allgayer, 2006).…”
Section: Discussionmentioning
confidence: 96%